Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Dana, Binyamin"'
Autor:
Mor Zigdon, Jasmin Sawaed, Lilach Zelik, Dana Binyamin, Shira Ben-Simon, Nofar Asulin, Rachel Levin, Sonia Modilevsky, Maria Naama, Shahar Telpaz, Elad Rubin, Aya Awad, Wisal Sawaed, Sarina Harshuk-Shabso, Meital Nuriel-Ohayon, Mathumathi Krishnamohan, Michal Werbner, Omry Koren, Sebastian E Winter, Ron N Apte, Elena Voronov, Shai Bel
Publikováno v:
PLoS Biology, Vol 22, Iss 1, p e3002486 (2024)
Acute gastrointestinal infection with intracellular pathogens like Salmonella Typhimurium triggers the release of the proinflammatory cytokine interleukin 1β (IL-1β). However, the role of IL-1β in intestinal defense against Salmonella remains uncl
Externí odkaz:
https://doaj.org/article/ca29f8c148af43b188b8262dbe5119eb
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-6 (2021)
Abstract Background Clostridioides difficile (C. difficile) is a major nosocomial pathogen that infects the human gut and can cause diarrheal disease. A dominant risk factor is antibiotic treatment that disrupts the normal gut microbiota. The aim of
Externí odkaz:
https://doaj.org/article/42ccf68f59904f47a8437369ef718e57
Autor:
Dana Binyamin, Nir Werbner, Meital Nuriel-Ohayon, Atara Uzan, Hadar Mor, Atallah Abbas, Oren Ziv, Raffaele Teperino, Roee Gutman, Omry Koren
Publikováno v:
Genome Medicine, Vol 12, Iss 1, Pp 1-9 (2020)
Abstract Background During aging, there is a physiological decline, an increase of morbidity and mortality, and a natural change in the gut microbiome. In this study, we investigated the influence of the gut microbiome on different metabolic paramete
Externí odkaz:
https://doaj.org/article/97701f9a909d4c0794f9eefcc7b44be1
Publikováno v:
Gut Pathogens, Vol 9, Iss 1, Pp 1-8 (2017)
Abstract Background Helicobacter pylori susceptibility to clarithromycin and fluoroquinolone can be determined through Etest or molecular assays. We examined the correlation between phenotypic susceptibility (MIC results) and genotypic susceptibility
Externí odkaz:
https://doaj.org/article/430bd3b301d543c78c93fb7f1e56f207
Publikováno v:
Frontiers in Microbiology, Vol 9 (2018)
Background:Clostridium difficile (C. difficile) is a major nosocomial pathogen that colonizes in the human gut. Recently, the U.S. FDA approved three new antimicrobial agents against gram-positive bacteria: Tedizolid, Dalbavancin, and Ceftobiprole. T
Externí odkaz:
https://doaj.org/article/a351ec885af54835bd02f951efbb1953
Publikováno v:
Frontiers in Microbiology, Vol 8 (2017)
Objective: To evaluate whether serum Procalcitonin (PCT) at the early stage of infection can serve as a potential biomarker for determining Clostridium difficile infection (CDI) severity.Methods: Fifty-four patients diagnosed with CDI were enrolled i
Externí odkaz:
https://doaj.org/article/a5dc9f39d1c14ac4bee66d8580d52eaa
Autor:
Hanan, Rohana, Maya, Azrad, Orna, Nitzan, Amos, Adler, Dana, Binyamin, Omry, Koren, Avi, Peretz
Publikováno v:
Journal of Clinical Medicine
Background: Clostridioides difficile infection (CDI) is a major nosocomial disease. The characteristics of different strains, the disease severity they cause, their susceptibility to antibiotics, and the changes they inflict on gut microbiome, have n
Autor:
Dana Binyamin, Paul Forsythe, Karen-Anne McVey Neufeld, Tanvi Javkar, Marya Kayyal, Omry Koren, M. Firoz Mian
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-1 (2020)
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Background: Clostridium difficile (C. difficile) is a major nosocomial pathogen that infects the human gut and can cause diarrheal disease. A dominant risk factor is antibiotic treatment that disrupts the normal gut microbiota. The aim of the study w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09af7552db0f0946d8cfc6e2d6e17474
https://doi.org/10.21203/rs.3.rs-52869/v1
https://doi.org/10.21203/rs.3.rs-52869/v1
Autor:
Henning Grønbæk, Ida Vogel, Hamutal Meiri, Dana Binyamin, David Danon, Adi Sharabi-Nov, Kypros H. Nicolaides, Kinneret Tenenbaum-Gavish, Holger Jon Møller, Omry Koren, Lihi Rothman, Eran Hadar, Ana Idelson
Publikováno v:
Tenenbaum-Gavish, K, Sharabi-Nov, A, Binyamin, D, Møller, H J, Danon, D, Rothman, L, Hadar, E, Idelson, A, Vogel, I, Koren, O, Nicolaides, K H, Gronbaek, H & Meiri, H 2020, ' First trimester biomarkers for prediction of gestational diabetes mellitus ', Placenta, vol. 101, pp. 80-89 . https://doi.org/10.1016/j.placenta.2020.08.020
Purpose: To develop a first trimester prediction model for gestational diabetes mellitus (GDM) using obesity, placental, and inflammatory biomarkers. Methods: We used a first trimester dataset of the ASPRE study to evaluate clinical and biochemical b